Ahmed O Elzoghby

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Nanomedicine (London, England)

Expert opinion on drug delivery

ACS omega

ACS biomaterials science & engineering

Harvard Medical School

Alexandria University Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School Jan 17 2018

United States

Postdoctoral Research Fellow :: Engineering in Medicine

Education History

Alexandria University Faculty of Pharmacy Jul 20 2009 - Sep 11 2012

Egypt

PHD :: Industrial Pharmacy

Publications

May S Freag, Mostafa T Mohammed, Arpita Kulkarni, Hagar E Emam, Krishna P Maremanda, Ahmed O Elzoghby
Modulating tumoral exosomes and fibroblast phenotype using nanoliposomes augments cancer immunotherapy. Science advances 10 (9) (2024)
May S Freag, Mostafa T Mohammed, Arpita Kulkarni, Hagar E Emam, Krishna P Maremanda, Ahmed O Elzoghby
Modulating tumoral exosomes and fibroblast phenotype using nanoliposomes augments cancer immunotherapy. Science advances 10 (9) (2024)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Yomna M Elmorshedy, Mohamed Teleb, Marwa A Sallam, Kadria A Elkhodairy, Mohammed Bahey-El-Din, Doaa Ahmad Ghareeb, Shaymaa A Abdulmalek, Shimaa A H Abdel Monaim, Adnan A Bekhit, Ahmed O Elzoghby, Fernando Albericio, Sherine N Khattab
Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer. Biomacromolecules (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Tasneem A Nasser, Rawan Adel, Abdelrahman Badr, Mohamed Teleb, Adnan A Bekhit, Kadria A Elkhodairy, Ahmed S Abdelhamid, Ahmed O Elzoghby
Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes. ACS omega 8 (5) (2023)
Riham M Abdelgalil, Sherine N Khattab, Shaker Ebrahim, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Marwa A Sallam, Ahmed O Elzoghby
Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics. ACS omega 8 (6) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Tasneem A Nasser, Rawan Adel, Abdelrahman Badr, Mohamed Teleb, Adnan A Bekhit, Kadria A Elkhodairy, Ahmed S Abdelhamid, Ahmed O Elzoghby
Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes. ACS omega 8 (5) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Sherine N Khattab, Shaker Ebrahim, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Marwa A Sallam, Ahmed O Elzoghby
Engineered Sericin-Tagged Layered Double Hydroxides for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible Cancer Nanotheranostics. ACS omega 8 (6) (2023)
Asmaa F Khafaga, Rehab Nabil Shamma, Ahmed Abdeen, Abdelmonem M Barakat, Ahmed E Noreldin, Ahmed O Elzoghby, Marwa A Sallam
Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies. Nanomedicine (London, England) 16 (19) (2021)
Dina A Hafez, Islam A Hassanin, Mohamed Teleb, Sherine N Khattab, Kadria A Elkhodairy, Ahmed O Elzoghby
Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy. Nanomedicine (London, England) 16 (25) (2021)
Doaa M Anwar, Mousa El-Sayed, Asmaa Reda, Jia-You Fang, Sherine N Khattab, Ahmed O Elzoghby
Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes. Expert opinion on drug delivery 18 (11) (2021)
Ahmed S AbdElhamid, Dina G Zayed, Lamia Heikal, Sherine N Khattab, Omar Y Mady, Sanaa A El-Gizawy, Ahmed O Elzoghby
Recent advances in polymer shell oily-core nanocapsules for drug-delivery applications. Nanomedicine (London, England) 16 (18) (2021)
Islam A Hassanin, Ahmed O Elzoghby
Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs. Expert opinion on drug delivery 17 (10) (2020)
Marian G Rofeal, Ahmed O Elzoghby, Maged W Helmy, Rowaida Khalil, Heba Khairy, Sanaa Omar
Dual Therapeutic Targeting of Lung Infection and Carcinoma Using Lactoferrin-Based Green Nanomedicine. ACS biomaterials science & engineering 6 (10) (2020)
Dina A Hafez, Kadria A Elkhodairy, Mohamed Teleb, Ahmed O Elzoghby
Nanomedicine-based approaches for improved delivery of phyto-therapeutics for cancer therapy. Expert opinion on drug delivery 17 (3) (2020)
Hadeer M Abdelaziz, Ahmed O Elzoghby, Maged W Helmy, Elsayeda-Zeinab A Abdelfattah, Jia-You Fang, Magda W Samaha, May S Freag
Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting. ACS biomaterials science & engineering 6 (2) (2020)
Mona A Abdelmoneem, Manar A Elnaggar, Ruwan S Hammady, Shaza M Kamel, Maged W Helmy, Mohammad A Abdulkader, Amira Zaky, Jia-You Fang, Kadria A Elkhodairy, Ahmed O Elzoghby
Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma. ACS applied materials & interfaces 11 (30) (2019)
Nayra M Kamel, Maged W Helmy, Magda W Samaha, Doaa Ragab, Ahmed O Elzoghby
Multicompartmental lipid-protein nanohybrids for combined tretinoin/herbal lung cancer therapy. Nanomedicine (London, England) 14 (18) (2019)
Nayra M Kamel, Maged W Helmy, Elsayeda-Zeinab Abdelfattah, Sherine N Khattab, Doaa Ragab, Magda W Samaha, Jia-You Fang, Ahmed O Elzoghby
Inhalable Dual-Targeted Hybrid Lipid Nanocore-Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells. ACS biomaterials science & engineering 6 (1) (2019)
Sarah A El-Lakany, Nazik A Elgindy, Maged W Helmy, Marwa M Abu-Serie, Ahmed O Elzoghby
Lactoferrin-decorated vs PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer. Expert opinion on drug delivery 15 (9) (2018)
Doaa M Anwar, Sherine N Khattab, Maged W Helmy, Mohamed K Kamal, Adnan A Bekhit, Kadria A Elkhodairy, Ahmed O Elzoghby
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. Bioconjugate chemistry 29 (9) (2018)

Ahmed O Elzoghby.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmed O Elzoghby